Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

55
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
55
Cancer Survival Analysis01:21

Cancer Survival Analysis

321
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
321
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

46
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
46
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

99
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
99
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

124
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
124

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preventing Early Onset GBS Neonatal Sepsis - Are Second Line Intrapartum Antibiotics Equivalent to No Antibiotics at All?

Journal of the American Board of Family Medicine : JABFM·2026
Same author

Antibiotic Treatment for Uncomplicated Acute Appendicitis in Children.

American family physician·2025
Same author

Less Aggressive Hydration May Be More in Acute Pancreatitis?

Journal of the American Board of Family Medicine : JABFM·2024
Same author

Consider this tool to reduce antibiotic-associated adverse events in patients with sepsis.

The Journal of family practice·2023
Same author

A "no-biopsy" approach to diagnosing celiac disease.

The Journal of family practice·2022
Same author

Platelet-Rich Plasma for Androgenic Alopecia.

American family physician·2022

Related Experiment Video

Updated: May 27, 2025

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

956

Gastric Cancer: Rapid Evidence Review.

Timothy Mott1, Carrie Gray2

  • 1Baldwin Health Family Medicine Residency, Foley, Alabama.

American Family Physician
|February 18, 2025
PubMed
Summary

Gastric cancer, a leading cause of cancer death, is linked to Helicobacter pylori. Early diagnosis via endoscopy is crucial for better survival rates, as prognosis depends heavily on disease stage.

Area of Science:

  • Oncology
  • Gastroenterology

Background:

  • Gastric cancer remains a significant global health challenge, despite decreasing incidence in some regions.
  • Risk factors are multifactorial, with a strong association with Helicobacter pylori infection.
  • Current screening methods like endoscopy lack definitive randomized controlled trial evidence for widespread benefit.

Purpose of the Study:

  • To summarize the current understanding of gastric cancer diagnosis, treatment, and prognosis.
  • To highlight the importance of early detection and multidisciplinary care.

Main Methods:

  • Review of current medical literature and clinical guidelines for gastric cancer.
  • Emphasis on diagnostic procedures, staging, and treatment modalities.
  • Discussion of prognostic factors and survival rates.

More Related Videos

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

10.8K
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

611

Related Experiment Videos

Last Updated: May 27, 2025

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

956
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

10.8K
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

611

Main Results:

  • Gastric cancer incidence and mortality rates vary globally, with higher rates outside the United States.
  • Patients often present with non-specific symptoms, delaying diagnosis.
  • Upper gastrointestinal endoscopy with biopsies is the recommended diagnostic tool.
  • Treatment strategies are tailored to disease extent, histopathology, and biomarkers.
  • Prognosis is strongly correlated with the stage at diagnosis, with localized disease having >70% 5-year survival versus <10% for metastatic disease.

Conclusions:

  • Early diagnosis and prompt, multidisciplinary treatment are critical for improving gastric cancer patient outcomes.
  • Prognosis is significantly better for localized disease compared to metastatic disease.